AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04407767 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Processing Therapy
Description: CPT is a brief therapy for PTSD predominantly based on cognitive theory. Traditionally delivered over 12 one-hour sessions weekly or twice weekly, CPT is now variable length depending on patient's recovery from PTSD. CPT is delivered in three phases: education, processing, and challenging and focuses on challenging beliefs and assumptions related to the trauma, oneself, and the world. Changing dysfunctional beliefs alters negative emotions emanating from those beliefs.
Study NCT05486078 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MD Tissue Collagen Medical Device
Description: The Experimental Group will be treated with 2-mL volume ultrasound-guided infiltration of: MD-Tissue (GUNA, Milan-Italy). Composition for 2 ml: collagen 100 micrograms Subjects will be treated with No.1 infiltration per week for 3 consecutive weeks. The infiltrations will be performed in an echoguided mode.~MD-Tissue Collagen Medical Device will be infiltrated into the trochanteric bursa and at the level of the tendons of the gluteus minimus and gluteus medius, particularly at the level of the most degenerated insertional areas.
Study NCT06063473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifarotene Cream 0.005%
Description: The study medication will be self-applied topically, on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days
Study NCT06063473 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The study medication will be self-applied topically, on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days
Study NCT05839834 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: RNA sequencing of peripheral blood cells
Study NCT06063473 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories)
Description: The study medication will be self-applied topically, on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days
Study NCT06234904 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IBR733 Cell Injection
Description: The minimum initial dose is 5.0×10\^9 cells and then escalate to 7.5×10\^9 cells and 10.0×10\^9 cells. Every 21 days is one cycle, and intravenous infusion is performed on day 1 and day 8 of each cycle.
Study NCT04889274 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 vaccine
Description: COVID-19 vaccine as offered by NHS England
Study NCT04889274 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: COVID-19 vaccine
Description: COVID-19 vaccine as offered by NHS England
Study NCT04889274 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 vaccine
Description: COVID-19 vaccine as offered by NHS England
Study NCT04889274 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Concentrate beetroot Juice
Description: Beetroot juice containing approximately 5mmol/l nitrate
Study NCT04889274 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Nitrate-deplete beetroot juice
Description: Beetroot juice with nitrate removed
Study NCT05580120 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online-supervised exercise group
Description: Participants in the online-supervised exercise group were provided with an online-supervised exercise program by using the video conferencing method three times a week for 6 weeks on the Zoom application. The exercise program was carried out synchronously
Study NCT05580120 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unsupervised-exercise training group
Description: The unsupervised-exercise training group was informed about how to do the same exercises by another researcher, a nurse academician, on the online platform by using the lecturing method. Each training intervention took approximately 30 minutes.
Study NCT05374486 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeuroExo co-robot neurorehabilitation system
Description: In this longitudinal study, adult subjects with hemiparesis due to chronic stroke will receive robotic-assisted upper-arm training through an EEG-based BMI control of robotic exoskeleton to study the changes in upper extremity motor function, cortical plasticity (using the EEG). After one screening visit, two baseline visits for EEG signal screens, six onsite training sessions will be provided with the NeuroExo system, followed by 60 home therapy sessions (2 sessions per day, 5 days per week for 6 weeks). If the participant have completed at least 50 sessions of neurotherapy at home, the participant will complete a set of measurements to assess function of the affected upper arm and brain activity within 3 days after the last session for post-assessment visit, and one-month post follow-up session. The total amount of time for this study is 16-20 weeks.
Study NCT05271487 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi-Step Botanical Skin Care Regimen
Description: The intervention includes 7 different topical products:~1. Cleanser~2. Toner~3. Oil Control Cream~4. Exfoliating Facial Scrub~5. Clay Mask~6. Acne Spot Treatment~7. Body Scrub
Study NCT04764890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: Electroacupuncture in several point
Study NCT04764890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual therapy
Description: Manual therapy in the lower spine.
Study NCT05763147 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Access Device Flushing
Description: locking and flushing the end of catheter line at the intervals of different drug treatment.
Study NCT05763147 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intravenous Access Device Flushing
Description: locking and flushing the end of catheter line at the intervals of different drug treatment.
Study NCT06328491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erdafitinib
Description: Protein Kinase Inhibitor
Study NCT04093505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemtuzumab Ozogamicin 147
Description: Induction therapy: Gemtuzumab Ozogamicin 3mg/m² on days 1,4 and 7
Study NCT04093505 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemtuzumab Ozogamicin 147
Description: Induction therapy: Gemtuzumab Ozogamicin 3mg/m² on days 1,4 and 7
Study NCT04093505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemtuzumab Ozogamicin 1
Description: Induction therapy: Gemtuzumab Ozogamicin 3mg/m² on day 1
Study NCT04093505 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemtuzumab Ozogamicin 1
Description: Induction therapy: Gemtuzumab Ozogamicin 3mg/m² on day 1
Study NCT04093505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glasdegib
Description: Consolidation \& Maintenance therapy Glasdegib 100mg on days 4 to 27
Study NCT04093505 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Consolidation \& Maintenance therapy Placebo 100mg on days 4 to 27
Study NCT04764890 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual therapy
Description: Manual therapy in the lower spine.
Study NCT05505994 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001
Description: DWP16001 A mg tablet
Study NCT05505994 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin
Description: Dapagliflozin tablet
Study NCT05505994 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DWP16001 Placebo
Description: DWP16001 Placebo tablet
Study NCT05505994 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin Placebo
Description: Dapagliflozin Placebo tablet
Study NCT05837169 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Description: The control group will be assessed with the study surveys at baseline, will not receive MBSR intervention for the following 8 weeks, and will subsequently be reassessed with the study surveys at the same time points as the intervention group. At the end of the recruitment and follow-up of all the participants, the study will end and the control group will be able to receive the MBSR intervention free of charge according to the preference of the participants.
Study NCT06422754 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Becure GmbH
Description: Becure Balance System
Study NCT06156293 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral prevention program for insomnia (CBP-I)
Description: CBP-I will be provided to participants once their districts are exposed.
Study NCT05076500 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy and blood sample collection
Description: A pre-treatment diagnostic biopsy sample plus 1 mandatory biopsy (during/post-radiotherapy \[irradiated site\]) will be collected from each participant.~Matched blood samples will be collected from participants at baseline, during/post-radiotherapy, and if radiotherapy continues after the on-treatment biopsy is taken, an additional end of treatment blood sample will be collected.
Study NCT05167539 — intervention group
Intervention type: PROCEDURE
Intervention: Aortic valve surgery
Description: mechanical aortic valve replacement versus ross procedure and stentless bioprothesis
Study NCT05289882 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PASS Program Condition:
Description: Participants randomized to this condition will be invited to take part in weekly ball hockey games (once per week), that will last approximately 60 minutes, and will be followed by opportunities to socially connect afterwards. The results of our feasibility study indicated that the PASS program acted as an important conduit to direct participants to other support services and resources (e.g., counseling, career transition centre, employment, education). Military veteran men are often reluctant to access such supports, especially if they attach stigma to such services (e.g., mental health services). At each site, a military veteran will be trained as a facilitator to operate as a conduit to refer participants to the relevant support services and agencies.
Study NCT05011435 — intervention group
Intervention type: DEVICE
Intervention: web-application for burnout
Description: Use of burnout advisor web-application for detection of professional burnout
Study NCT04992507 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anesthesia Procedure
Description: Given TIVA
Study NCT04992507 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: General Anesthesia Procedure
Description: Given inhaled volatile anesthetics
Study NCT04992507 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo surgical resection
Study NCT04992507 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resection
Description: Undergo surgical resection
Study NCT06515535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid
Description: Topical tranexamic acid will be applied after placental delivery on the placental bed for 5 minutes by using a sterile towel soaked with 2g tranexamic acid (Kapron, Amoun, Cairo, Egypt) (4 ampules 500ug) diluted in 100ml of sodium chloride 0.9%
Study NCT06515535 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous tranexamic acid
Description: Intravenous tranexamic acid will be given in the form of an IV infusion of 1g of tranexamic acid (2 ampules 500ug) diluted with 20 ml of 5% glucose administered just after delivery of the fetus.
Study NCT06515535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid
Description: Intravenous tranexamic acid will be given in the form of an IV infusion of 1g of tranexamic acid (2 ampules 500ug) diluted with 20 ml of 5% glucose administered just after delivery of the fetus.
Study NCT04743570 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo treatment
Description: Active drug/placebo is given for the first 5 days of admission.
Study NCT04743570 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylnaltrexone treatment
Description: Active drug/placebo is given for the first 5 days of admission.
Study NCT05143502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast
Description: Montelukast is a leukotrienes antagonist which has proven efficacious in chronic inflammatory conditions of the airways, including allergic rhinitis, asthma, and aspirin-exacerbated respiratory disease (AERD), all diseases that often coexist with CRSwNP.~We will use oral Montelukast (montelukast 10 mg, once a day) for 3 monthes
Study NCT05143502 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone
Description: Oral Prednisolone 40 mg/day for two weeks.
Study NCT05143502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: Oral Prednisolone 40 mg/day for two weeks.
Study NCT06354556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-1893 tablet
Description: HRS-1893 tablet single dose
Study NCT06354556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verapamil tablet
Description: Verapamil tablet 80 mg tid
Study NCT05243888 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: self-sampling
Description: eligible women receive at their home address a self-sampling kit in addition to the conventional invitation letter
Study NCT05488834 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Critical-Care Pain Observation Tool
Description: The Critical Care Pain Observation Tool (CPOT) was created to help assess pain in critically ill patients who were unable to self-report pain.~The CPOT instrument evaluates facial expression, body movement, muscle tension, and compliance with ventilator or vocalisation to evaluate an individual's pain. The total score ranges from 0 to 8, where 8 is the worst pain. Patients are observed for 60 seconds while resting and during nociceptive procedures such as turning or wound dressings to detect any change in behaviour that could indicate pain. Further, the patient must be observed before and at the peak of analgesia medications administered to evaluate pain treatment effectiveness.
Study NCT06279338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine Injection
Description: On the basis of the conventional transplantation treatment regimen, combining azacitidine injection with BUCY2 conditioning regimen (azacitidine 75 mg/m2/d for -11 days to -5 days, cytarabine 2 g/m2 q12h for -8 days to -7 days, cyclophosphamide 1.8 g/m2/d for -6 days to -5 days, busulfan 3.2 mg/kg/d for -4 days to -2 days)
Study NCT05143502 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasone Furoate
Description: fluticasone furoate nasal: (50 micrograms /spray ) 100 micrograms (2 sprays) in each nostril twice daily
Study NCT05143502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate
Description: fluticasone furoate nasal: (50 micrograms /spray ) 100 micrograms (2 sprays) in each nostril twice daily
Study NCT05662995 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lung ultrasound
Description: Lung ultrasound will be performed with the patient in supine position (with or without left uterine displacement, depending on clinical circumstances). A phased-array transducer will be used for lung ultrasound and will be used for the assessment of B-lines, which arise from the pleural line and extend to the bottom of the screen and move with the sliding lung
Study NCT05533190 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wysa AI chatbot mental health app
Description: Wysa is a guided self-help and triaging tool delivered to patients via an app. It includes a chatbot and makes use of a wide range of clinically underpinned modules to provide mental health support.
Study NCT05521373 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound cervical selective nerve root block
Description: A (7-12) MHz linear transducer will be applied to the symptomatic side of the neck in the transverse plane. The targeted nerve root of each patient will be identified by moving the transducer cranially from the C7 transverse process as a reference point.~After the targeted nerve root identified, a needle will be gently introduced toward the dorsal aspect of the nerve root under real-time US guidance with an in-plane approach. The needle tip will be placed between the nerve root and posterior tubercle outside of the intervertebral foramen and the vessels will be around the nerve root with color Doppler. On confirmation of the absence of abnormal findings and careful aspiration, 3 cc of the treatment drug composed of dexamethasone (10 mg) and 0.2% lidocaine, will be injected under real-time US guidance
Study NCT05521373 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound and fluoroscopy-guided cervical selective nerve root block
Description: The targeted transverse process was identified by slowly moving the probe in all directions with the 7th cervical spine transverse process as the reference point. a spinal needle 22 G was inserted. First, 1 ml of the contrast media was injected. The antero-posterior images were obtained to confirm the distribution or spread pattern of the injected contrast media with C-arm fluoroscopy. The following steps were initiated after confirming for proper shadowed contrast of the nerve root and absence of intravascular injection of the contrast media. Three cc of the treatment drug, composed of dexamethasone (10 mg) and 0.5 % lidocaine will be injected after confirming the absence of abnormal findings.
Study NCT05040191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Education(control)
Description: The application was made on the model that allows nasogastric tube application and the anatomical structure in the nasogastric region is seen. The student can experience the skill of applying a nasogastric tube to the nasogastric or orgastric region on this model. In the nursing skills laboratory, students were given a demonstration of nasogastric tube application on a model.
Study NCT05040191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Haptic interactive virtual reality simulation training
Description: Haptic interactive virtual reality simulation technology; It functions by using haptic gloves that are interactive, visually enhanced, containing three-dimensional video and animation, wearable by students. This program has been developed by a software developer who is an expert in the field of information technologies, using the unreal program with a nine-generation computer with a game engine. All the necessary steps in the NGT application have been in simulation.
Study NCT05040191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Haptic interactive computer-based simulation training
Description: Clinical tvr (tactile simulator) produced by a foreign commercial company used in nursing education was used. Clinical tvr simulation applications can be accessed online or downloaded to a computer. This simulator; It functions by using an interactive, visually enhanced 2D, animated, haptic arm that can be held by students like a pen. It includes applications such as nasogastric tube placement, urinary bladder catheter placement, heart massage. These applications can be realized through both mouse and haptic arm computer input devices. clinical tvr; It is a simulator that incorporates the enhanced benefits of haptic feedback through the use of haptic technology. This simulator provides a near-realistic sensory experience where the learner can practice a skill as it actually is. Computer-based simulation with haptic interaction was used in this study with the haptic arm in NGT application skill.
Study NCT05324202 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Cynosure Cynergy Nd:YAG Laser 1064nm
Description: The Nd:YAG Laser 1064nm is intended to be used as a treatment option in individuals suffering from low-risk basal cell carcinoma(s).
Study NCT05359068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPH3127 tablet
Description: 1 tablet
Study NCT05359068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPH3127 tablet
Description: 2 tablets
Study NCT05359068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPH3127 tablet
Description: 4 tablets
Study NCT05359068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan
Description: 1 valsartan capsule
Study NCT05151614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 MG
Description: Colchicine 0.5 mg tab 1x2 for 1 week then o.5mg tab. 1x1 for another week + the standard therapy ( total duration of colchicine 14 days).
Study NCT05193487 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: inferior alveolar nerve block
Description: inferior alveolar nerve block using Articaine 4% with 1/200000 Adrenaline and a traditional needle injection
Study NCT05193487 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intra-osseous mandibular anaesthesia
Description: intra-osseous mandibular anaesthesia using Articaine 4% with 1/200000 Adrenaline and a special intra-osseous injection device
Study NCT06520280 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: polyamide and 3D printed complete denture
Description: pts. receive 2 sets of complete dentures made from polyamide and 3d printed to use